ArticleFrontiers in medicine2026

CYP2C19 intermediate and poor metabolizer statuses may be associated with coronary atherosclerosis among patients with type 2 diabetes mellitus.

Nan Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.